tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SDZXF Stock Latest News

Sandoz price target raised to CHF 41 from CHF 39 at Berenberg
The FlySandoz price target raised to CHF 41 from CHF 39 at Berenberg
4d ago
Sandoz Launches First Interchangeable Denosumab Biosimilars in US
PremiumCompany Announcements
Sandoz Launches First Interchangeable Denosumab Biosimilars in US
28d ago
Sandoz Launches Pyzchiva® Autoinjector in Europe, Enhancing Biosimilar Leadership
PremiumCompany Announcements
Sandoz Launches Pyzchiva® Autoinjector in Europe, Enhancing Biosimilar Leadership
1M ago
Sandoz launches Pyzchive autoinjector in Europe
PremiumThe Fly
Sandoz launches Pyzchive autoinjector in Europe
1M ago
Sandoz price target lowered to CHF 39 from CHF 41 at Berenberg
PremiumThe Fly
Sandoz price target lowered to CHF 39 from CHF 41 at Berenberg
2M ago
Sandoz upgraded to Outperform from Sector Perform at RBC Capital
PremiumThe FlySandoz upgraded to Outperform from Sector Perform at RBC Capital
2M ago
Sandoz Achieves 3% Net Sales Growth in Q1 2025, Eyes Further Biosimilar Launches
Premium
Company Announcements
Sandoz Achieves 3% Net Sales Growth in Q1 2025, Eyes Further Biosimilar Launches
2M ago
Sandoz Partners with Henlius to Expand Cancer Treatment Access
Premium
Company Announcements
Sandoz Partners with Henlius to Expand Cancer Treatment Access
2M ago
Sandoz announces collaboration license agreement with Henlius
PremiumThe Fly
Sandoz announces collaboration license agreement with Henlius
2M ago
Sandoz Shareholders Approve Key Proposals at AGM
PremiumCompany Announcements
Sandoz Shareholders Approve Key Proposals at AGM
3M ago
Sandoz shareholders approve all resolutions at Annual General Meeting
PremiumThe Fly
Sandoz shareholders approve all resolutions at Annual General Meeting
3M ago
Sandoz Files Antitrust Lawsuit Against Amgen Over Biosimilar Blockade
PremiumCompany Announcements
Sandoz Files Antitrust Lawsuit Against Amgen Over Biosimilar Blockade
3M ago
Sandoz files antitrust litigation against Amgen regarding Enbrel
PremiumThe FlySandoz files antitrust litigation against Amgen regarding Enbrel
3M ago
AMGN
Sandoz Files Antitrust Lawsuit Against Amgen Over Enbrel Market Dominance
Premium
Company Announcements
Sandoz Files Antitrust Lawsuit Against Amgen Over Enbrel Market Dominance
3M ago
Sandoz price target lowered to CHF 46.50 from CHF 50 at Barclays
Premium
The Fly
Sandoz price target lowered to CHF 46.50 from CHF 50 at Barclays
3M ago
Sandoz price target lowered to CHF 46 from CHF 48 at JPMorgan
PremiumThe Fly
Sandoz price target lowered to CHF 46 from CHF 48 at JPMorgan
3M ago
Sandoz Strengthens Financial Position with New Credit Facility and Bond Issuance
PremiumCompany Announcements
Sandoz Strengthens Financial Position with New Credit Facility and Bond Issuance
3M ago
Sandoz price target raised to CHF 44 from CHF 42 at RBC Capital
PremiumThe Fly
Sandoz price target raised to CHF 44 from CHF 42 at RBC Capital
3M ago
Sandoz upgraded to Buy from Hold at Deutsche Bank
PremiumThe Fly
Sandoz upgraded to Buy from Hold at Deutsche Bank
4M ago
Sandoz price target lowered to CHF 38 from CHF 41 at Morgan Stanley
PremiumThe FlySandoz price target lowered to CHF 38 from CHF 41 at Morgan Stanley
4M ago
Sandoz Group Ltd Reports Strong Growth and Strategic Expansion
Premium
Company Announcements
Sandoz Group Ltd Reports Strong Growth and Strategic Expansion
4M ago
SDZXF
Sandoz Group Ltd: Strong Financial Performance and Resilient Outlook Justify Buy Rating
Premium
Ratings
Sandoz Group Ltd: Strong Financial Performance and Resilient Outlook Justify Buy Rating
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >